Vimta Labs Reports Strong Q1 FY27 Results: Net Profit Rises 11.4% YoY to ₹21.04 Crore

Vimta Labs Limited, a prominent Indian contract research and testing organization, has announced its unaudited financial results for the first quarter ended June 30, 2026 (Q1 FY27). Supported by steady demand across its testing and laboratory services, the company posted an 11.4% year-on-year growth in net profit to ₹21.04 crore (₹210.42 million).

Key Financial Highlights (Q1 FY27 vs Q1 FY26 & Q4 FY26)

Revenue from Operations: Grew 11.8% year-on-year (YoY) to ₹109.07 crore (₹1,090.74 million), compared to ₹97.56 crore (₹975.64 million) in Q1 FY26. Sequentially, revenue remained steady relative to the ₹109.25 crore (₹1,092.45 million) recorded in Q4 FY26.

Total Income: Rose 13.7% YoY to ₹112.89 crore (₹1,128.86 million), up from ₹99.31 crore (₹993.13 million) in the corresponding quarter of the previous fiscal, supported by ₹3.81 crore in other income.

Profit Before Tax (PBT): Climbed 12.2% YoY to ₹28.34 crore (₹283.38 million), up from ₹25.26 crore (₹252.62 million) in Q1 FY26 and ₹29.05 crore in Q4 FY26.

Profit After Tax (PAT): Reached ₹21.04 crore (₹210.42 million), registering an 11.4% YoY increase over ₹18.89 crore (₹188.94 million) in Q1 FY26 and holding stable against ₹21.11 crore (₹211.13 million) in Q4 FY26.

Earnings Per Share (EPS): Basic EPS for the quarter expanded to ₹4.71 per share (face value ₹2 each), up from ₹4.25 in Q1 FY26. Diluted EPS stood at ₹4.66 per share.

Expenditure Breakdown

Total expenses for Q1 FY27 amounted to ₹84.55 crore (₹845.48 million), up from ₹74.05 crore in Q1 FY26 and ₹82.95 crore in Q4 FY26.

Key expense drivers for the quarter included:

Cost of Materials Consumed & Testing Expenditure: ₹22.63 crore (up from ₹18.80 crore in Q1 FY26).

Employee Benefits Expense: ₹29.42 crore (up from ₹27.82 crore in Q1 FY26).

Depreciation & Amortisation Expense: ₹12.55 crore (up from ₹9.86 crore in Q1 FY26).

Other Expenses: ₹19.67 crore (compared to ₹17.25 crore in Q1 FY26).

Finance Costs: Reduced to ₹0.24 crore (down from ₹0.32 crore in Q1 FY26).

Total tax expense for the period stood at ₹7.20 crore (₹71.96 million), comprising current tax of ₹5.81 crore, deferred tax expense of ₹1.44 crore, and prior period adjustments of ₹0.04 crore.

Comprehensive Income & Capital Structure

Total Comprehensive Income for Q1 FY27 came in at ₹21.03 crore (₹210.27 million) after accounting for minor re-measurements of net defined benefit liabilities.

As of June 30, 2026, Vimta Labs Limited's paid-up equity share capital stood at ₹8.93 crore (₹89.34 million) consisting of equity shares with a face value of ₹2 each.

Shares of Vimta Labs Limited was last trading in BSE at Rs. 559.50 as compared to the previous close of Rs. 564.35. The total number of shares traded during the day was 9187 in over 396 trades.

The stock hit an intraday high of Rs. 564.45 and intraday low of 550.00. The net turnover during the day was Rs. 5102053.00.

Source : Equity Bulls

Keywords

VimtaLabs INE579C01029 HealthcareServices Q1FY27 Q1FY2027 ResultUpdate